Transdermal scopolamine-induced neurologic deficits in patients with cancer.

M. H. Friedberg, Michael Glantz

Research output: Contribution to journal › Article › peer-review

All Science Journal Classification (ASJC) codes

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{92f54b04696844de91524f59109a11a5,

title = "Transdermal scopolamine-induced neurologic deficits in patients with cancer.",

author = "Friedberg, {M. H.} and Michael Glantz",

year = "1994",

month = may,

language = "English (US)",

volume = "77",

pages = "141--142",

journal = "Rhode Island medicine",

issn = "1061-222X",

publisher = "Rhode Island Medical Society",

number = "5",

}

TY - JOUR

T1 - Transdermal scopolamine-induced neurologic deficits in patients with cancer.

AU - Friedberg, M. H.

AU - Glantz, Michael

PY - 1994/5

Y1 - 1994/5

UR - http://www.scopus.com/inward/record.url?scp=0028437309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028437309&partnerID=8YFLogxK

M3 - Article

C2 - 8019013

AN - SCOPUS:0028437309

SN - 1061-222X

VL - 77

SP - 141

EP - 142

JO - Rhode Island medicine

JF - Rhode Island medicine

IS - 5

ER -